Li D W, Dong P, Wang F, et al. Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxia-inducible factor-1α[J]. Asian Pac J Cancer Prev, 2013, 14(8): 4853-4858. [2]Jenckel F, Knecht R. State of the art in the treatment of laryngeal cancer[J]. Anticancer Res, 2013, 33(11): 4701-4710 . [3]Xu Y Y, Wu T T, Zhou S H, et al. Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma: Hep-2 cells: an in vitro study[J]. Int J Clin Exp Pathol, 2014, 7(7): 3938-3947. [4]Halasi M, Gartel A L. FOX(M1) news--it is cancer[J]. Mol Cancer Ther, 2013, 12(3): 245-254. [5]Halasi M, Gartel A L. Targeting FOXM1 in cancer[J]. Biochem Pharmacol, 2013, 85(5): 644-652. [6]Hegde N S, Sanders D A, Rodriguez R, et al. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton[J]. Nat Chem, 2011, 3(9): 725-731. [7]Jiang L Z, Wang P, Deng B, et al. Overexpression of Forkhead Box M1 transcription factor and nuclear factor-κB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis[J]. Hum Pathol, 2011, 42(8): 1185-1193. [8]林力, 邓碧, 寿铸, 等. 硫链丝菌肽对人喉癌Hep-2细胞生长及FoxM1表达的影响[J]. 第三军医大学学报, 2012, 34(20): 2086-2089. [9]Zhou J, Wang Y, Wang Y, et al. FOXM1 modulates cisplatin sensitivity by regulating EXO1 in ovarian cancer[J]. PLoS One, 2014, 9(5): e96989. [10]Kwok J M, Peck B, Monteiro L J, et al. FOXM1 confers acquired cisplatin resistance in breast cancer cells[J]. Mol Cancer Res, 2010, 8(1): 24-34. [11]Chetty C, Bhoopathi P, Rao J S, et al. Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells[J]. Int J Cancer, 2009, 124(10): 2468-2477. [12]Tan Y, Raychaudhuri P, Costa R H. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes[J]. Mol Cell Biol, 2007, 27(3): 1007-1016. [13]Halasi M, Gartel A L. Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage[J]. PLoS One, 2012, 7(2): e31761. [14]Wang Y, Wen L, Zhao S H, et al. FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients[J]. Lung Cancer, 2013, 79(2): 173-179. [15]Cory S, Huang D C, Adams J M. The Bcl-2 family: roles in cell survival and oncogenesis［J］. Oncogene, 2003, 22(53): 8590-8607. ？
[2]
林力,邓碧,寿铸,等.硫链丝菌肽对人喉癌Hep-2细胞生长及FoxM1表达的影响[J].第三军医大学学报,2012,34(20):2086. Lin Li,Deng Bi,Shou Zhu,et al.Effect of thiostrepton on proliferation and FoxM1 expression in human laryngocarcinoma Hep-2 cell line[J].J Third Mil Med Univ,2012,34(16):2086. [2]于超,李艮平,陈鸿雁.硫链丝菌肽抑制FOXM1表达后对裸鼠鼻咽癌移植瘤的抑制作用[J].第三军医大学学报,2015,37(20):2038. Yu Chao,Li Genping,Chen Hongyan.Effect of thiostrepton on inhibiting human nasopharyngeal carcinoma through down-regulating FoxM1 expression in nude mice[J].J Third Mil Med Univ,2015,37(16):2038.
